# US 2025/0367102 A1 · Personal care composition comprising a biodegradable cationic polymer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367102 A1
- Document ID: US20250367102A1
- Status: Published application
- Kind: A1
- Application number: 19/228,212
- Filed: 2025-06-04
- Published: 2025-12-04
- Earliest claimed: 2024-06-04
- Assignees: The Procter & Gamble Company
- Applicants: The Procter & Gamble Company
- Inventors: Eric Scott JOHNSON; Brennan Alexander SCHILLING; Brandon Scott LANE; Parth Rajesh SHAH
- Web page: https://patentgrep.com/patent/US20250367102A1

## CPC

- A61K 8/73: Polysaccharides
- A61K 8/737: {Galactomannans, e.g. guar; Derivatives thereof}
- A61K 8/4926: {having six membered rings}
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61Q 5/006: {Antidandruff preparations}
- A61Q 5/02: Preparations for cleaning the hair
- A61Q 5/12: Preparations containing hair conditioners
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention is directed to a personal care composition comprising from about 8 to about 20% of one or more surfactants; from about 0.01 to about 10% of scalp care active; from about 0.01 to about 5% of one or more cationic polymer; from about 0.1% to about 5% of a cationically modified poly alpha-1,6-glucan ether compound; and wherein the composition has an increase in deposition of the scalp care active when compared to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

## Claims

### Claim 1

A personal care composition comprising
a. from about 8 to about 20% of one or more surfactants;
b. from about 0.01 to about 10% of scalp care active;
c. from about 0.01 to about 5% of one or more cationic polymer;
d. from about 0.1% to about 5% of a cationically modified poly alpha-1,6-glucan ether compound; and wherein the composition has an increase in deposition of the scalp care active when compared to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 2 (depends on 1)

A personal care composition according to claim 1, wherein the cationically modified poly alpha-1,6-glucan ether compound:
comprises a cationically modified poly alpha-1,6-glucan substituted with at least one positively charged organic group;
comprises a backbone of glucose monomer units wherein at least 65% of the backbone glucose monomer units are linked via alpha-1,6-glycosidic linkages;
has a degree of substitution of from 0.001 to 3; and
is characterized by one or more of the following i-iii:
i. a weight average degree of polymerization of from 5 to 6000,
ii. a weight average molecular weight of from 1000 to 500,000 daltons,
iii. derived from a poly alpha-1,6-glucan having a weight average molecular weight of from 900 to 450,000 daltons determined prior to substitution with the least one positively charged organic group.

### Claim 3 (depends on 1)

A personal care composition according to claim 1, wherein from about 5% to about 35% of the backbone glucose monomer units have branches via alpha-1,2 and/or alpha-1,3-glycosidic linkages.

### Claim 4 (depends on 2)

A personal care composition according to claim 2, wherein the positively charged organic group comprises a substituted ammonium group.

### Claim 5 (depends on 4)

A personal care composition according to claim 4, wherein the substituted ammonium group comprises a quaternary ammonium group comprising at least one C10 to C16 alkyl group.

### Claim 6 (depends on 4)

A personal care composition according to claim 4, wherein the substituted ammonium group comprises a quaternary ammonium group comprising a trimethylammonium group.

### Claim 7 (depends on 2)

A personal care composition according to claim 2, wherein the positively charged organic group comprises a quaternary ammonium hydroxyalkyl group.

### Claim 8 (depends on 1)

A personal care composition according to claim 1, comprising from about from 0.01% to 5% of the cationically modified poly alpha-1,6-glucan ether compound by weight of the personal care composition.

### Claim 9 (depends on 1)

A personal care composition according to claim 1, wherein the cationically modified poly alpha-1,6-glucan ether compound has a degree of substitution of from about 0.01 to about 0.3.

### Claim 10 (depends on 1)

A personal care composition according to claim 1, wherein the cationically modified poly alpha-1,6-glucan ether compound has a weight average molecular weight of from about 50,000 to about 500,000 daltons.

### Claim 11 (depends on 1)

A personal care composition according to claim 1, wherein the cationically modified poly alpha-1,6-glucan ether compound has a charge density of 0.05 to 3 meq/gm.

### Claim 12 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer has a charge density (CD) of from about 0.05 to about 7.0 meq/gm.

### Claim 13 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer has a charge density (CD) of from about 0.7 to about 3.0 meq/gm.

### Claim 14 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer has a molecular weight (MW) of from about 300,000 to about 2,600,000 g/mol.

### Claim 15 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer has a molecular weight (MW) of from about 700,000 to about 2,600,000 g/mol.

### Claim 16 (depends on 1)

A personal care composition according to claim 1 wherein the composition has at least a 10% increase in deposition when compared to a composition with to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 17 (depends on 1)

A personal care composition according to claim 1 wherein the composition has at least a 20% increase in deposition when compared to a composition with to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 18 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer has a molecular weight (MW) of from about 700,000 to about 1,500,000 g/mol and a charge density (CD) of from about 0.5 to about 1.6 meq/gm.

### Claim 19 (depends on 1)

A personal care composition according to claim 1, wherein the anionic detersive surfactant is select from alkyl sulfates, alkyl ether sulfates, acyl glycinates, acyl sarcosinates, acyl glutamates, acyl alaninates, sulfosuccinates, isethionates, sulfonates, sulfoacetates, glucose carboxylates, alkyl ether carboxylates, acyl taurates, sodium, ammonium or potassium salts of these, and mixtures thereof.

### Claim 20 (depends on 1)

The personal care composition according to claim 1, wherein the co-surfactant is selected from aliphatic secondary and tertiary amines, wherein at least one aliphatic substituent contains 8 to 18 carbon atoms and at least one aliphatic substituent contains an anionic selected from carboxy, sulfonate, sulfate, phosphate, and phosphonate.

### Claim 21 (depends on 20)

The personal care composition according to claim 20, wherein the co-surfactant is selected from cocoamphoacetate, cocoamphodiacetate, lauroamphoacetate, lauroamphodiacetate, and mixtures thereof.

### Claim 22 (depends on 1)

The personal care composition according to claim 1, wherein the co-surfactant is selected from derivatives of aliphatic quaternary ammonium, phosphonium, and sulfonium compounds, wherein at least one aliphatic substituent contains 8 to 18 carbon atoms and at least one aliphatic substituent contains an anionic group selected from carboxy, sulfonate, sulfate, phosphate and phosphonate.

### Claim 23 (depends on 22)

The personal care composition according to claim 22, wherein the co-surfactant is selected from cocamidopropyl betaine, lauramidopropyl betaine and mixtures thereof.

### Claim 24 (depends on 1)

A personal care composition according to claim 1 further comprising from about 0.25% to about 15% of the co-surfactants.

### Claim 25 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymers are selected from the group consisting of a cationic guar polymer, a cationic non-guar galactomannan polymer, a cationic tapioca polymer, a cationic copolymer of acrylamide monomers and cationic monomers, a synthetic, non-crosslinked, cationic polymer, which may or may not form lyotropic liquid crystals upon combination with the detersive surfactant, a cationic cellulose polymer and mixtures thereof.

### Claim 26 (depends on 1)

A personal care composition according to claim 1 wherein the one or more cationic polymer is selected from the group consisting of guar hydroxypropyltrimonium chloride, salts of hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, a cationic copolymer of acrylamide monomers and cationic monomers, a synthetic, non-crosslinked, cationic polymer, which may or may not form lyotropic liquid crystals upon combination with the detersive surfactant.

### Claim 27 (depends on 1)

A personal care composition according to claim 1 wherein the scalp care active selected from the group consisting of hydroxyl pyridone, azoles, climbazole, ketoconazole, salicylic acid, polyvalent metal salts of pyrithione, sulfur, and selenium sulfide.

### Claim 28 (depends on 27)

A personal care composition according to claim 27 wherein the hydroxyl pyridone is piroctone olamine.

### Claim 29 (depends on 27)

A personal care composition according to claim 27, wherein the polyvalent metal salt of pyrithione is zinc pyrithione.

### Claim 30 (depends on 1)

A personal care composition according to claim 1, wherein the composition has at least a 1× increase in deposition when compared to a composition with to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 31 (depends on 1)

A personal care composition according to claim 1, wherein the composition has at least a 2× increase in deposition when compared to a composition with to a control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 32 (depends on 1)

A personal care composition according to claim 1, wherein there is an increase in coacervation as measured by a decreasing % T and resulting in an increase in scalp care active deposition compared to control composition with no cationically modified poly alpha-1,6-glucan ether compound.

### Claim 33

A personal care composition comprising
a. from about 8 to about 20% of one or more surfactants;
b. from about 0.01 to about 10% of scalp care active;
c. from about 0.01 to about 5% of one or more cationic polymer;
d. from about 0.1% to about 5% of a cationically modified poly alpha-1,6-glucan ether compound; wherein the composition is free of sulfated surfactants and wherein the composition has an increase in deposition of the scalp care active when compared to a control composition with no cationically modified poly alpha-1,6-glucan ether.
